Skip to content
  • info@qps.com
  • English
    • Chinese (Simplified)
qps-30-logo-144ppi
  • Company
  • Locations
    • USA
      • Delaware
      • Miami
      • Missouri
    • Europe
      • The Netherlands
      • Austria
    • Taiwan
      • CTPS
      • NKSP
      • Qualitix
    • India
  • Insights
Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt
  • Services
      Bioanalysis >
      • Assay Finder
      • Biomarkers and Translational Medicine
      • Biotherapeutics
      • Cell and Gene Therapy
      • CLIA
      • Genomics
      • ICP-MS (Mass Spectrometry)
      • Small Molecules
      Preclinical Services >
      • DMPK
      • Biotransformation
      • Micro Autoradiography (MARG)
      • Preclinical DDI Studies
      • Protein Binding
      • Radiolabeled ADME
      • Quantitative Whole-Body Autoradiography (QWBA)
      • IND Package
      • Pharmacology
      • Toxicology
      Lab Services >
      • Leukopak Services
      • Peripheral Blood Mononuclear Cells (PBMCs)
      Clinical Services >
      • Early Stage Clinical Trials
      • Clinical Research Services
      • Project Management and Site Monitoring
      • Site Identification and Qualification
      • Global Medical Affairs
      • Medical Writing Services
      • Pharmacovigilance
      • Global Regulatory Affairs
      • Central Safety Lab
      • Clinical Trial Kits
      • Clinical Biostatistics Consultancy
      • Clinical Data Management
      • Study Recruitment
      • Real World Evidence Studies
  • Resources
    • Our Science
      • Expert Interviews
      • Podcasts
      • Scientific Posters
      • Scientific Reference Articles
      • Thought Leadership
      • Webinars
      • White Papers
    • Our Expertise
      • Dermatology
        • Dermal and Transdermal
      • Endocrinology
      • Inflammatory Bowel Disease
      • Neuropsychiatry
      • Obesity Clinical Trials
      • Oncology Clinical Trials
      • Rheumatology
      • Vaccines
      • Women’s Health
    • Services Materials
      • Brochures
        • Brochures – Chinese
        • Brochures – Japanese
        • Brochures – Korean
      • Case Studies
      • eBooks
      • Ultimate Guides
        • Oncology
        • Oligonucleotides
        • Gene Therapy
      • Videos
    • Guidance Documents
  • Blog
    • Infographics
  • Careers
  • Contact
QPS Logo
qps-30-logo-144ppi
  • Company
  • Locations
    • USA
      • Delaware
      • Miami
      • Missouri
    • Europe
      • The Netherlands
      • Austria
    • Taiwan
      • CTPS
      • NKSP
      • Qualitix
    • India
  • Insights
  • Services
    • Bioanalysis
      • Assay Finder
      • Biomarkers and Translational Medicine
      • Biotherapeutics
      • Cell and Gene Therapy
      • CLIA
      • Genomics
      • ICP-MS (Mass Spectrometry)
      • Small Molecules
    • Preclinical Services
      • DMPK
        • Biotransformation
        • Micro Autoradiography (MARG)
        • Preclinical DDI Studies
        • Protein Binding
        • Radiolabeled ADME
        • Quantitative Whole-Body Autoradiography (QWBA)
      • IND Package
      • Pharmacology
      • Toxicology
    • Lab Services
      • Leukopak Services
      • Peripheral Blood Mononuclear Cells (PBMCs)
    • Clinical Services
      • Early Stage Clinical Services
      • Clinical Research Services
        • Project Management and Site Monitoring
        • Site Identification and Qualification
        • Global Medical Affairs
          • Medical Writing Services
          • Pharmacovigilance
        • Global Regulatory Affairs
        • Central Safety Lab
        • Clinical Trials Kits
        • Clinical Biostatistics Consultancy
        • Clinical Data Management
        • Study Recruitment
      • Real World Evidence Studies
  • Resources
    • Our Science
      • Expert Interviews
      • Podcasts
      • Scientific Posters
      • Scientific Articles
      • Thought Leadership
      • Webinars
      • White Papers
    • Our Expertise
      • Dermatology
        • Dermal and Transdermal
      • Endocrinology
      • Inflammatory Bowel Disease
      • Neuropsychiatry
      • Obesity Clinical Trials
      • Oncology Clinical Trials
      • Rheumatology
      • Vaccines
      • Women’s Health
    • Service Materials
      • Brochures
        • Brochures – Chinese
        • Brochures – Japanese
        • Brochures – Korean
      • Case Studies
      • eBooks
      • Ultimate Guides
        • Oncology
        • Oligonucleotides
        • Gene Therapy
      • Videos
    • Guidance Documents
  • Blog
    • Blog Infographics
  • Careers
  • Contact

Preclinical Micro Autoradiography (MARG)

Home / Preclinical Micro Autoradiography (MARG)
QPS-logo-white-tagline

Over 800 Assays Available

download-ios
download-google

Preclinical Micro Autoradiography (MARG)

Home / Preclinical Micro Autoradiography (MARG)
QPS-logo-white-tagline

All MARG studies are done in the QPS DMPK labs in Newark, Delaware, USA

Preclinical Micro Autoradiography (MARG) studies are a specialized technique used in drug development and research to investigate the distribution and localization of radiolabeled compounds within tissues at a microscopic level. This method provides insights into the pharmacokinetics, metabolism, and target engagement of a drug candidate in preclinical animal models.

Here are key aspects of preclinical Micro Autoradiography studies:

1. Radiolabeling of Compounds:
  • Objective: Incorporate a radioactive label (e.g., tritium, carbon-14) into the drug molecule of interest.
  • Methods: Synthesize radiolabeled compounds for administration to preclinical animal models.
  • Significance: Enables tracking of the drug's journey within the body, including its distribution, metabolism, and localization in tissues.
2. Animal Administration:
  • Objective: Administer radiolabeled compounds to laboratory animals.
  • Methods: Employ various routes of administration, such as oral, intravenous, or subcutaneous injection, to mimic different dosing regimens.
  • Significance: Replicates the drug exposure scenarios that would occur in clinical settings, allowing researchers to study the fate of the drug within the body.
3. Tissue Collections:
  • Objective: Harvest tissues from the animals after a specified period post-drug administration.
  • Methods: Collect a range of tissues, including organs and target tissues, for subsequent analysis.
  • Significance: Provides material for microscopic examination of radiolabel distribution in different tissues.
4. Cryosectioning:
  • Objective: Prepare thin tissue sections for microscopic analysis.
  • Methods: Freeze tissues and cut them into thin slices (cryosections) for autoradiographic examination.
  • Significance: Allows for detailed examination of drug distribution within tissues at a cellular or subcellular level.
5. Autoradiography Imaging:
  • Objective: Visualize and quantify the distribution of radioactivity within tissue sections.
  • Methods: Expose tissue sections to X-ray film or a phosphor imaging plate to capture the emitted radioactive signals.
  • Significance: Generates images that reveal the spatial distribution of the radiolabeled drug, indicating areas of high or low drug concentration.
6. Quantitative Analysis:
  • Objective: Quantify the radioactivity in different tissue regions.
  • Methods: Use image analysis software to measure radioactivity levels and correlate them with specific anatomical structures.
  • Significance: Provides quantitative data on drug distribution, aiding in the assessment of tissue penetration and target engagement.
7. Data Interpretation:
  • Objective: Interpret the MARG data to draw conclusions about drug behavior in tissues.
  • Methods: Integrate MARG findings with other pharmacokinetic and pharmacodynamic data to understand the relationship between drug exposure and biological effects.
  • Significance: Guides decision-making in drug development, helping refine dosing regimens, optimize formulations, and assess the potential for off-target effects.

MARG studies are valuable tools in drug development, offering detailed insights into the in vivo behavior of drug candidates. They are particularly useful for understanding drug distribution patterns in specific tissues and organs, aiding researchers in making informed decisions during the drug development process.

MARG studies involve the use of specialized equipment and instruments to conduct radiolabeling, administer radiolabeled compounds, collect tissues, prepare tissue sections, and perform autoradiography imaging.

Here are the key machines and equipment commonly used in MARG studies:

1. Radiolabeling Equipment:
  • Liquid Scintillation Counter: Used for measuring the radioactivity of the labeled compounds during the radiolabeling process.
2. Animal Administration:
  • Dosing Apparatus: Devices for accurate administration of radiolabeled compounds to laboratory animals, including options for various routes such as oral gavage, intravenous injection, or subcutaneous injection.
3. Tissue Collection:
  • Surgical Instruments: Tools for the precise and sterile collection of tissues from animals post-drug administration.
4. Cryosectioning:
  • Cryostat: A machine that allows researchers to cut thin sections of frozen tissues for autoradiography. It maintains low temperatures to prevent tissue thawing during sectioning.
5. Autoradiography Imaging:
  • X-ray Film Cassette or Phosphor Imaging Plate: Used to capture the emitted radioactive signals from tissue sections during autoradiography.
  • Darkroom Equipment: Facilities with safelights and other equipment for handling X-ray films without exposing them to light.
6. Quantitative Analysis:
  • Image Analysis Software: Software tools for quantifying radioactivity levels in different regions of the autoradiographic images.
7. Data Safety Equipment:
  • Radiation Safety Equipment: Personal protective equipment (PPE) and shielding measures to ensure the safety of researchers handling radioactive materials.

It’s important to note that working with radioactive materials requires adherence to strict safety protocols and compliance with regulatory guidelines. Researchers conducting MARG studies must have appropriate training in radiation safety, and laboratories conducting such studies should be equipped with radiation safety measures and facilities.

The specific models and brands of equipment may vary depending on the laboratory and its capabilities, but the mentioned categories represent the essential components involved in conducting MARG studies. Researchers typically choose equipment based on factors such as the nature of the radiolabeled compound, the study objectives, and available resources.

Links to Relevant Documents

Leadership

Linkedin-in

Deborah J. Watson, Ph.D.

Group Leader – DMPK (In Vivo)
Linkedin-in

Deborah J. Watson, Ph.D.

Group Leader – DMPK (In Vivo)
Linkedin-in

Laura Gwinn

Research Associate I – DMPK (QWBA)
Linkedin-in

Laura Gwinn

Research Associate I – DMPK (QWBA)

Time is of the essence in Drug Development.

Contact the QPS Business Development Team Today!

Your link to a rewarding career.

Join the QPS team and be part of our growing organization.

Submit Your Resume

About qps

  • Mission, Vision, and Values
  • QPS History
  • Bioanalysis Milestones
  • Locations
  • Meet Our People
  • Blog
  • Careers
  • Privacy Policy
  • Mission, Vision, and Values
  • QPS History
  • Bioanalysis Milestones
  • Locations
  • Meet Our People
  • Blog
  • Careers
  • Privacy Policy

Preclinical Services

  • Assay Finder
  • DMPK
  • IND Package
  • Pharmacology
  • Toxicology
  • Assay Finder
  • DMPK
  • IND Package
  • Pharmacology
  • Toxicology

Clinical Services

  • Early Phase Clinical Trials
  • Leukopak Services
  • Global Medical Affairs
  • Global Regulatory Affairs
  • Therapeutic Areas
  • Early Phase Clinical Trials
  • Leukopak Services
  • Global Medical Affairs
  • Global Regulatory Affairs
  • Therapeutic Areas

Resources

  • Brochures
  • Case Studies
  • Conferences
  • eBooks
  • Guidance Documents
  • Milestones
  • Scientific Posters
  • Scientific Reference Articles
  • Thought Leadership
  • Videos/Webinars
  • White Papers
  • Brochures
  • Case Studies
  • Conferences
  • eBooks
  • Guidance Documents
  • Milestones
  • Scientific Posters
  • Scientific Reference Articles
  • Thought Leadership
  • Videos/Webinars
  • White Papers

Headquarters Location

Delaware Technology Park,
3 Innovation Way,
Newark, DE 19711

  • +1 512 350 2827
  • +1 302 369 5601, option 0
  • info@qps.com
  • Sales: +1 512 350 2827
  • HQ: +1 302 369 5601, option 0
  • info@qps.com

Connect with us

Linkedin-in Youtube Facebook-f Instagram
download-ios
download-google
qps-assay-finder-black

Subscribe To Our Blog

"*" indicates required fields

Name
Address
Confirmation*
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Copyright © 2025 · QPS Holdings. All Rights Reserved | Web Design by 417 Marketing.
Contact Us
Scroll to Top

Notifications